The explanation to that could be found in many mechanisms of resistance to immunotherapy such as the presence of immunosuppressive factors in local tumor microenvironment (TME), downregulation of major histocompatibility complex (MHC) protein expression on tumor cell surface, tumor clonal heterogeneity, and tumor dedifferentiation and stemness [10]. The gene discussed is HLA-C; the disease is neoplasm.